NCT06095375
Clinical Trial Detail
Contact
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06095375 |
| Title | Regorafenib With Temozolomide With or Without RT in MGMT-Methylated, IDH Wild-type GBM Patients (REGOMA-2) |
| Acronym | REGOMA-2 |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | Yes |
| Sponsors | Istituto Oncologico Veneto IRCCS |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | ITA |
CKB BOOST